An interventional study of High-Flow Tracheal Therapy in Tracheostomized Patients, sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Not yet recruiting at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This monocentric, randomized crossover study aims to assess the impact of high-flow tracheal therapy (HFT) on the rheological properties of tracheobronchopulmonary secretions in tracheostomized patients. The primary objective is to compare the viscoelastic characteristics of secretions collected with and without HFT. Secondary objectives include evaluating the effects of HFT on dyspnea, patient comfort, and secretion appearance. The study will take place at Cliniques Universitaires Saint-Luc, with adult tracheostomized patients undergoing standard care.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the lead sponsor of 350 studies on the registry; 64 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: High-Flow Tracheal Therapy
Device: Airvo 2 (Fisher \& Paykel Healthcare) Settings: Flow rate start at 40L/min and will be adapted according to tolerance; temperature aimed at 37°C or 34°C according to tolerance, FiO₂ set (if needed) according to SpO2 target values.
Critical stress (σc)
The rheological properties measured using Rheomuco (Rheonova) will be sampled during a suctioning procedure. The critical stress σc = G\*(γc).γc, where G\*(γc) is the viscoelastic modulus measured at the critical strain, is the measured stress at which this transition occurs. See the description of the other rheological outcomes in the secondary outcomes.
Time frame: Measured three times: at baseline, after one hour, after 4 hours
Dyspnea (modified Borg scale)
The modified Borg Scale (from 0 : no dyspnea; to 10 : maximal dyspnea) will be used
Time frame: Measured two times: at baseline and after 4 hours
Patient Comfort (Visual Analog Scale - VAS)
The VAS (from 0 : extremely comfortable; to 10 : extremely uncomfortable) will be used
Time frame: Measured two times: at baseline and after 4 hours
Secretion Appearance (Murray Scale)
The Murray scale define the following secretion appearance: * Mucoid * Mucopurulent * Purulent
Time frame: Measured two times: at baseline and after 4 hours
Viscoelastic modulus (G*)
The rheological properties measured using Rheomuco (Rheonova) will be sampled during a suctioning procedure. The ratio of the stress to the strain, the viscoelastic modulus G\* , describes the molecular network force in response to shear. In viscoelastic materials, the viscous dissipation shifts in time the stress response to the imposed strain, which is quantified by the damping ratio tan δ. Both G\* and tan δ provide the viscous and elastic moduli, G' and G''. See the description of the other rheological outcomes in the secondary outcomes.
Time frame: Measured three times: at baseline, after one hour, after 4 hours
Damping ratio (tan δ)
The rheological properties measured using Rheomuco (Rheonova) will be sampled during a suctioning procedure. At given deformation, a damping ratio above 1 would describe a predominantly viscous material (G'' \> G'), i.e. that behaves like a liquid, whereas a damping ratio below 1 denotes a predominantly elastic material (G' \> G''), that exhibits a solid-like behavior.
Time frame: Measured three times: at baseline, after one hour, after 4 hours
Critical strain (γc)
The rheological properties measured using Rheomuco (Rheonova) will be sampled during a suctioning procedure. The viscoelastic characteristics are measured at increasing strains, ranging from about 1 % to about 10000 %. At a critical strain value, γc, typically around or above 1000 % for sputa, the G' and G'' curves cross over (the damping ratio overcomes 1). Beyond this critical point, the sample becomes predominantly viscous over elastic (fluid-like) under strain and starts to flow. See the description of the other rheological outcomes in the secondary outcomes.
Time frame: Measured three times: at baseline, after one hour, after 4 hours
Start is estimated for Jan 2027; primary completion for Jan 2028, 12 months later.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: start Jun 2026 → Jan 2027, primary completion Aug 2027 → Jan 2028 and completion Aug 2027 → Aug 2028.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain →